-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Xtant Medical Hldgs, Lowers Price Target to $1

Benzinga·03/31/2026 15:02:02
Listen to the news
BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and lowers the price target from $1.5 to $1.